2009年以前:業績(論文)

(過去4年間英文のみ掲載)

  1. Daimon M, et al. Local dysfunction and asymmetrical deformation of mitral annular geometry in ischemic mitral regurgitation: A novel computerized 3D echocardiographic analyses. Echocardiography 25: 414-423, 2009
  2. Daimon M, et al. Normal Values of Echocardiographic Parameters and Their Relation with Age in a Healthy Japanese Population: The JAMP study. Cic J 72: 1859-1866, 2008
  3. Miyata M, et al. Beneficial effects of waon therapy on patients with chronic heart failure: Results of a prospective multicenter study. J Cardiol 52: 79-85, 2008
  4. Sumiyoshi M, et al. Two case of Pilsicainide Intoxication showing the Brugada-type Electrocardiographic Findings and Incessant Wide QRS tachycardia. J arrhythmia 24: 219-223, 2008
  5. Kubota N, et al. Therapy with statins and aspirin enhances long-term outcome of percutaneous coronary intervention. Heart and Vessels 23: 35-9, 2008
  6. Kasai T, et al. Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention. Hypertension Res 31: 235-41, 2008
  7. Kasai T, et al. Influence of Diabetes on >10 year outcomes after percutaneous coronary intervention. Heart and Vessels 23: 149-54, 2008
  8. Kasai T, et al. Pioglitazone attenuates neointimal thickening via suppression of the early inflammatory response in a porcine coronary after stenting. Atherosclerosis 197: 612-9, 2008
  9. Kasai T, et al. The relationship between the metabolic syndrome defined by various criteria and the extent of coronary artery disease. Atherosclerosis 31: 235-41, 2008
  10. Miyauchi K, et al. Effectiveness of Statin Eluting-Stent on Early Inflammatory Response and Neointimal Thickness in a Porcine Coronary Model. Circ J 72: 832-8, 2008
  11. Ikeda E, et al. Dipyridamole therapy improves long-term survival after complete revascularization in patients with impaired cardiac function. -A propensity analysis-. Circ J 72: 1481-86, 2008
  12. Kajimoto K, et al. Metabolic Syndrome predicts 10-year mortality in non-diadetic patients following coronary artery bypass surgery. Circ J 72: 1481-86, 2008
  13. Sumiyoshi K, et al. Deletion of the fc receptors gamma chain preserves endothelial function affected by hypercholesterolaemia in mice fed on a high-fat diet. Cardiovasc Res 80: 463-70, 2008
  14. Miyazaki T, et al. Insulin response to oral glucose load is associated with coronary artery disease in subjects with normal glucose tolerance. J Atheroscler Thromb 15: 6-12, 2008
  15. Seki E, et al. Effects of a phase III cardiac rehabilitation program on physical status and lipid profiles in elderly patients with coronary artery disease: Juntendo cardiac rehabilitation program (J-CARP). Circ J 72: 1230-4, 2008
  16. Kume A, et al. High levels of saturated very long-chain fatty acid (hexacosanoic acid; C26:0) in whole blood are associated with metabolic syndrome in Japanese men. Diabetes Res Clin Pract. 80: 259-64, 2008
  17. Tokano T, et al. Prolonged asystole during head-up tilt test in patient with malignant neurocardiogenic syncope. J Arrhythmia 24: 76-80, 2008
  18. Kurebayashi N, et al. Aberrant cell-to-cell coupling in Ca2+-overloaded guinea pig ventricular muscles. Am J Physiol Cell Physiol 294: C1419-29, 2008
  19. Hayashi H, et al. Clinical efficacy of bepridil for class I antiarrhythmic drug-induced atrial flutter in patients with paroxysmal atrial fibrillation. J Arrhythmia 24: 71-75, 2008
  20. Hashimoto R, et al. Differentiation of Mouse Bone Marrow Stromal Cells into Functional Smooth Muscle Cells. J Jpn Coll Angiol 48: 299-306, 2008
  21. Kasai T, et al. Propensity analysis of 12 years outcome after bypass graft or balloon angioplasty in patients with multivessel coronary artery disease. J Cardiol 52: 186-94, 2008
  22. Nagai R, Daida H, et al. JCADII Investigators. Rationale and design of a study to examine lower targets for low-density lipoprotein-cholesterol and blood pressure in coronary artery disease patients. Circ J 72: 515-20, 2008
  23. Tamiya E, et al. Acute heart failure due to mitral regurgitation responding dramatically to carperitide (hANP): A case report. Int J Cardiol 28: 125, 2008
  24. Tamiya E, et al. Intravascular ultrasound assessment of atherosclerotic plaque in the aorta. Int J Cardiol 123: 283-7, 2008.
  25. Kasai T, et al. Influence of diabetes on >10-year outcomes after percutaneous coronary intervention. Heart Vessels 23: 149-54, 2008
  26. Miyata M, et al. Beneficial effects of waon therapy on patients with chronic heart failure: Results of a prospective multicenter study. J Cardiol 52: 79-85, 2008
  27. Teramoto T, Daida H, et al: Committee for Epidemiology and Clinical Management of Atherosclerosis. Primary hyperlipidemia. J Atheroscler Thromb 15: 49-51, 2008
  28. Tsutsumi-Ishii Y, et al. Low potency of chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein. Int Immunol 20: 199-208, 2008
  29. Dohi T, et al. Bi-level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ J 72: 1100-5, 2008
  30. Fujimoto H, et al. Primary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance alone. J Cardiol 51: 18-24, 2008
  31. Watada H, et al. Letter by watada et al regarding article, "two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesion". Circulation 118: e680, 2008
  32. Yamashiro K, et al. The frequency of cardiac valvular regurgitation in parkinson's disease. Mov Disord 23: 935-41, 2008.
  33. Yanagisawa N, et al. Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages. Lipids Health Dis 7: 48 2008
  34. Zhou H, et al. Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. Biochem Biophys Res Commun 369: 213-9, 2008.
  35. Takayama T, Daida H, et al. Rationale and design for a study using intravascular ultrasound to evaluate effects of rosuvastatin on coronary artery atheroma in japanese subjects: COSMOS study (coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects). Circ J 71: 271-5, 2007
  36. Njaman W, et al. Rationale and design for a study using intravascular ultrasound to evaluate effects of rosuvastatin on coronary artery atheroma in japanese subjects: COSMOS study (coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects). Int Heart J 48: 523-32, 2007
  37. Goto Y, Daida H, et al. Japanese Cardiac Rehabilitation Survey Investigators. Poor implementation of cardiac rehabilitation despite broad dissemination of coronary interventions for acute myocardial infarction in japan: A nationwide survey. Circ J 71: 173-9, 2007.
  38. Inoue K, et al. Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris. Arterioscler. Thromb. Vasc. Biol. 27: 161-167, 2007
  39. Kasai T, et al. Long-term (11-year) statin therapy following Percutaneous Coronary Iuntevention improves clinical outcomes but not associated with increased malignancy. Int J Cardiol 114: 210-217, 2007
  40. Suzuki H, et al. Clinical efficacy of benidipine for vasospastic angina pectoris. Arzneimittelforschung 57: 20-5, 2007
  41. Yan C, et al. Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop. Circ Res 100: 510-9, 2007
  42. Teramoto T, Daida H, et al. Risk factors of atherosclerotic diseases. executive summary of japan atherosclerosis society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese. J Atheroscler Thromb 14: 267-77, 2007
  43. Teramoto T, Daida H, et al. Executive summary of japan atherosclerosis society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 14: 45-50, 2007
  44. Teramoto T, Daida H, et al. Committee for Epidemiology and Clinical Management of,Atherosclerosis. Goals of dyslipidemia management. J Atheroscler Thromb 14: 209-12, 2007
  45. Teramoto T, Daida H, et al. Japan Atherosclerosis Society (JAS) Committee for Epidemiology and Clinical Management of Atherosclerosis. Diagnostic criteria for dyslipidemia. executive summary of japan atherosclerosis society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 14: 155-8, 2007
  46. Konishi H, et al. Dimethylarginine Dimethylaminohydrolase enhances endothelial repair after vascular injury. J Am Coll Cardiol 49: 1099-105, 2007
  47. Sydow K, Konishi H, et al. Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity. Arterioscler Thromb Vasc Biol 28: 692-7, 2008
  48. Fujimoto H, Dohi T, et al. Use and long-term outcome of bare metal stent implantation in the drug-eluting stent era. J Cardiol. 49: 305-12, 2007
  49. Warabi E, et al. Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species. Free Radic Biol Med 42: 260-9, 2007
  50. Daimon M, et al. Multi-focus setting improves the heterogeneity of myocardial opacification in intravenous contrast echocardiography. J Cardiol 40: 11-17, 2007
  51. Daimon M, et al. Dynamic change in mitral annular area and motion during percutaneous mitral annuloplasty for ischemic mitral regurgitation: preliminary animal study with real-time 3D echocardiography. J Am Soc Echocardiogr 20 :381-388, 2007
  52. Toyoda T, Daimon M, et al. Diurnal variation in coronary flow velocity reserve in healthy man. J Echocardiogr 5: 72-78, 2007
  53. Tamiya E, et al. Evaluation of the heart and great vessel calcification by conventional computed tomography in hemodialysis patients. Ren Fail 29: 37-40, 2007
  54. Kawata T, et al. Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist. Am Heart J 151: 798 (e9-15), 2006
  55. Njaman W, et al. Impact of aspirin treatment on long-term outcome (over 10-years) after percutaneous coronary intervention. Int Heart J 47: 37-45, 2006
  56. Kasai T, et al. Efficacy of peroxisome proliferative activated receptor (PPAR)-alpha ligands, fenofibrate, on intimal hyperplasia and constrictive remodeling after coronary angioplasty in porcine models. Atherosclerosis 188: 274-80, 2006
  57. Miyauchi K, et al. Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS) -Rationale and Design. Cir J 70: 1624-1628, 2006
  58. Itoh S, et al. Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium. Circulation 113: 1787-98, 2006
  59. Maekawa N, et al. Inhibiting p90 ribosomal S6 kinase prevents (Na+)-H+ exchanger-mediated cardiac ischemia-reperfusion injury. Circulation 113: 2516-23, 2006
  60. Woo CH, et al. Inhibiting p90 ribosomal S6 kinase prevents (Na+)-H+ exchanger-mediated cardiac ischemia-reperfusion injury. J Biol Chem 281: 32164-74, 2006
  61. Kasai T, et al. Prognostic value of the metabolic syndrome on Long-term (more than 10 years) Outcomes in Patient Undrgoing Percutaneous Coronary Iuntevention. Circ J 70: 1531-1537, 2006
  62. Azuma K, et al. Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in goto-kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 345: 688-93, 2006
  63. Kawamori R, Daida H, et al. Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J). BMC Cardiovasc Disor 6:39, 2006
  64. Kawamori R, Kadowaki T, Daida H, et al. Positioning of PROactive and its clinical application in japan--a new direction in diabetes care discussed by diabetology and circulatory disease specialists: Discussion. Nippon Rinsho 64: 581-7, 2006
  65. Kawamura M and Daida H. Complications related to procedures for acute coronary syndrome. Nippon Rinsho 64: 788-93, 2006.
  66. Shimada K, et al. T helper 1/T helper 2 balance and HMG-CoA reductase inhibitors in acute coronary syndrome: Statins as immunomodulatory agents? Eur Heart J 27: 2916-8, 2006
  67. Shimada K, et al. Efficacy and safety of controlled-release isosorbide-5-mononitrate in japanese patients with stable effort angina pectoris. Int Heart J 47: 695-705, 2006
  68. Tanaka A, et al. Insulin and nateglinide reduce monocyte adhesion to endothelial cells in goto-kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 350: 195-201, 2006.
  69. Tasaki H, et al. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: A japanese multicenter clinical trial. Ther Apher Dial 10: 32-41, 2006
  70. Yasuda M, et al. Clinical evaluation of adverse effects during bepridil administration for atrial fibrillation and flutter. Circ J Jun 70: 662-6, 2006
  71. Song BL, et al. Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma. Biochem J. 394: 617-26, 2006
  72. Inoue K, et al. Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. Arterioscler Thromb Vasc Biol. 2652-9, 2006
  73. Daimon M, et al. Mitral Valve Repair with Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty for Ischemic Mitra Regurgitation: Early Echocardiographic Results from Multi-center Study. Circulation 114 (Suppl): I588-I593, 2006.
  74. Sekine T, et al. Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy. Heart Vessels 21:350-355, 2006